Anúncio
Anúncio
CMPX
Compass Therapeutics, Inc. Common Stock
5.34
USDPatrocinado
+0.17
+3.38%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
5.40
+0.06
+1.03%
Relatórios de Lucros CMPX
Rácio de surpresa positiva
CMPX separação 9 de 17 últimas estimativas.
53%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.10
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+25.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-9.09%
Compass Therapeutics, Inc. Common Stock earnings per share and revenue
On 05 de nov. de 2025, CMPX reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 42.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an aumentar of 25.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Compass Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Compass Therapeutics, Inc. Common Stock reported EPS of -$0.08, beating estimates by 42.98%, and revenue of $0.00, 0% as expectations.
How did the market react to Compass Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.79%, changed from $3.79 before the earnings release to $3.82 the day after.
When is Compass Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Compass Therapeutics, Inc. Common Stock's next earnings report?
Based on 16
analistas, Compass Therapeutics, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio